NEWS

UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest 11/19/2024
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections 11/13/2024
Enlaza Therapeutics marries covalent and biologic drugs
Enlaza Therapeutics marries covalent and biologic drugs 11/12/2024
Female Founders Social Event
Female Founders Social Event 11/07/2024
Minutia: Shifting the T1D Paradigm
Minutia: Shifting the T1D Paradigm 10/29/2024
BeeKeeperAI and Topcon Team Up to Accelerate Healthcare from the Eye
BeeKeeperAI and Topcon Team Up to Accelerate Healthcare from the Eye 10/11/2024
Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment
Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment 10/09/2024
Cardiology Panel Focused on the University’s Expertise
Cardiology Panel Focused on the University’s Expertise 10/03/2024
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS Patients
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS Patients 10/03/2024
Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing Enterocolitis
Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing Enterocolitis 09/18/2024
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate 09/12/2024
Brain Tumor Forum Places UCSF Technology in the Room with Venture Capital
Brain Tumor Forum Places UCSF Technology in the Room with Venture Capital 09/05/2024
Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member
Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member 09/05/2024
ArsenalBio Announces $325 Million Financing to Advance Programmable Cell Therapy Programs through Clinical Development
ArsenalBio Announces $325 Million Financing to Advance Programmable Cell Therapy Programs through Clinical Development 09/04/2024
Biotechs take multiplexing into animal models to accelerate drug discovery
Biotechs take multiplexing into animal models to accelerate drug discovery 08/16/2024